Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Flares of mixed cryoglobulinaemia vasculitis after vaccination against SARS-CoV-2.
Visentini M, Gragnani L, Santini SA, Urraro T, Villa A, Monti M, Palladino A, Petraccia L, La Gualana F, Lorini S, Marri S, Madia F, Stefanini L, Basili S, Fiorilli M, Ferri C, Zignego AL, Casato M. Visentini M, et al. Among authors: urraro t. Ann Rheum Dis. 2022 Mar;81(3):441-443. doi: 10.1136/annrheumdis-2021-221248. Epub 2021 Nov 24. Ann Rheum Dis. 2022. PMID: 34819272 No abstract available.
Long-term effect of HCV eradication in patients with mixed cryoglobulinemia: a prospective, controlled, open-label, cohort study.
Gragnani L, Fognani E, Piluso A, Boldrini B, Urraro T, Fabbrizzi A, Stasi C, Ranieri J, Monti M, Arena U, Iannacone C, Laffi G, Zignego AL; MaSVE Study Group. Gragnani L, et al. Among authors: urraro t. Hepatology. 2015 Apr;61(4):1145-53. doi: 10.1002/hep.27623. Epub 2015 Feb 10. Hepatology. 2015. PMID: 25431357 Clinical Trial.
Combined treatment with antiviral therapy and rituximab in patients with mixed cryoglobulinemia: review of the literature and report of a case using direct antiviral agents-based antihepatitis C virus therapy.
Urraro T, Gragnani L, Piluso A, Fabbrizzi A, Monti M, Fognani E, Boldrini B, Ranieri J, Zignego AL. Urraro T, et al. Case Reports Immunol. 2015;2015:816424. doi: 10.1155/2015/816424. Epub 2015 Mar 1. Case Reports Immunol. 2015. PMID: 25815218 Free PMC article.
Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre study.
Quartuccio L, Zuliani F, Corazza L, Scaini P, Zani R, Lenzi M, Tavoni A, Sebastiani M, Baldovino S, Urraro T, Saccardo F, Sbreglia C, Mazzaro C, Pioltelli P, Fraticelli P, Filippini D, Gabrielli A, Perrella O, Scarpato S, Roccatello D, Zignego AL, Ferri C, Bombardieri S, Pietrogrande M, Monti G, Galli M, De Vita S. Quartuccio L, et al. Among authors: urraro t. J Autoimmun. 2015 Sep;63:88-93. doi: 10.1016/j.jaut.2015.07.012. Epub 2015 Aug 5. J Autoimmun. 2015. PMID: 26255249 Free article. Clinical Trial.
Virological and Clinical Response to Interferon-Free Regimens in Patients with HCV-Related Mixed Cryoglobulinemia: Preliminary Results of a Prospective Pilot Study.
Gragnani L, Piluso A, Urraro T, Fabbrizzi A, Fognani E, Petraccia L, Genovesi A, Giubilei L, Ranieri J, Stasi C, Monti M, Zignego AL. Gragnani L, et al. Among authors: urraro t. Curr Drug Targets. 2017;18(7):772-785. doi: 10.2174/1389450117666160208145432. Curr Drug Targets. 2017. PMID: 26853322 Review.
17 results